• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High frequency of HLA-DQB1*0301 allele in patients with pure ocular cicatricial pemphigoid.

作者信息

Chan L S, Wang T, Wang X S, Hammerberg C, Cooper K D

机构信息

Department of Dermatology, University of Michigan School of Medicine, Ann Arbor.

出版信息

Dermatology. 1994;189 Suppl 1:99-101. doi: 10.1159/000246943.

DOI:10.1159/000246943
PMID:8049575
Abstract

Two factors, is classification and its immunogenetics, may have contributed to an incomplete understanding of the pathogenic mechanism in the disease group commonly termed 'cicatricial pemphigoid'. We have previously demonstrated that pure ocular cicatricial pemphigoid (OCP) is a unique clinical and immunopathological entity. In an effort to better define the immunogenetic characteristics for patients with pure OCP, we performed HLA typing for the class II MHC gene HLA-DQB10301 allele, by amplifying genomic DNA extracted from patients with polymerase chain reaction, followed by hybridization with a sequence-specific oligonucleotide probe on dot-blotted and Southern-blotted amplified DNA samples. Ninety percent (9/10) of patients with pure OCP had the DQB10301 allele, in contrast to 52% (17/33) of normal individuals who had the DQB10301 allele. The high frequency of the HLA-DQB10301 allele in patients with pure OCP may point to a distinct immunogenetic pattern and possibly a distinct pathomechanism for the disease.

摘要

相似文献

1
High frequency of HLA-DQB1*0301 allele in patients with pure ocular cicatricial pemphigoid.
Dermatology. 1994;189 Suppl 1:99-101. doi: 10.1159/000246943.
2
Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid.
J Invest Dermatol. 1997 Feb;108(2):129-32. doi: 10.1111/1523-1747.ep12332352.
3
Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.瘢痕性类天疱疮临床变体中的常见主要组织相容性复合体II类标志物。
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7747-51. doi: 10.1073/pnas.91.16.7747.
4
HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity.主要影响口腔的意大利黏膜类天疱疮患者的HLA - DQB1等位基因
Br J Dermatol. 2001 Nov;145(5):805-8. doi: 10.1046/j.1365-2133.2001.04448.x.
5
Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.眼瘢痕性类天疱疮和假眼瘢痕性类天疱疮中抗基底膜带抗体的差异。
Curr Eye Res. 1996 May;15(5):521-32. doi: 10.3109/02713689609000763.
6
Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients.
Curr Eye Res. 1992 Dec;11(12):1233-8. doi: 10.3109/02713689208999549.
7
HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians.
Eur J Dermatol. 1998 Jul-Aug;8(5):330-3.
8
Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.黏膜类天疱疮:HLA - DQB1*0301与所有受累临床部位相关,且可能与抗基底膜IgG产生有关。
Br J Dermatol. 2001 Sep;145(3):406-14. doi: 10.1046/j.1365-2133.2001.04380.x.
9
Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid.DQw7(DQB1*0301)与瘢痕性类天疱疮的关联。
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11579-82. doi: 10.1073/pnas.88.24.11579.
10
Ocular cicatricial pemphigoid. A case report of monozygotic twins discordant for the disease.眼部瘢痕性类天疱疮。一对单卵双胞胎患该病不一致的病例报告。
Arch Ophthalmol. 1995 Feb;113(2):202-7. doi: 10.1001/archopht.1995.01100020086034.

引用本文的文献

1
The Immunogenetics of Autoimmune Blistering Diseases.自身免疫性水疱病的免疫遗传学。
Adv Exp Med Biol. 2022;1367:173-212. doi: 10.1007/978-3-030-92616-8_8.
2
Ocular Manifestations and Management of Autoimmune Bullous Diseases.自身免疫性大疱性疾病的眼部表现与治疗
J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):195-210. doi: 10.4103/jovr.jovr_86_18.